NO863139L - Fremgangsmaate ved fremstilling av nye benzamider. - Google Patents

Fremgangsmaate ved fremstilling av nye benzamider.

Info

Publication number
NO863139L
NO863139L NO863139A NO863139A NO863139L NO 863139 L NO863139 L NO 863139L NO 863139 A NO863139 A NO 863139A NO 863139 A NO863139 A NO 863139A NO 863139 L NO863139 L NO 863139L
Authority
NO
Norway
Prior art keywords
procedure
preparation
new benzamides
benzamides
new
Prior art date
Application number
NO863139A
Other languages
English (en)
Other versions
NO863139D0 (no
NO168706B (no
NO168706C (no
Inventor
Armando Vega Noverola
Jose Manuel Prieto Soto
Fernando Pujol Noguera
Robert Geoffrey Willi Spickett
Original Assignee
Fordonal Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fordonal Sa filed Critical Fordonal Sa
Publication of NO863139D0 publication Critical patent/NO863139D0/no
Publication of NO863139L publication Critical patent/NO863139L/no
Publication of NO168706B publication Critical patent/NO168706B/no
Publication of NO168706C publication Critical patent/NO168706C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/66—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having a hetero atom as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO863139A 1985-08-06 1986-08-04 Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-heterosyklisk substituerte benzamider. NO168706C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858519707A GB8519707D0 (en) 1985-08-06 1985-08-06 Chemical compounds

Publications (4)

Publication Number Publication Date
NO863139D0 NO863139D0 (no) 1986-08-04
NO863139L true NO863139L (no) 1987-02-09
NO168706B NO168706B (no) 1991-12-16
NO168706C NO168706C (no) 1992-03-25

Family

ID=10583372

Family Applications (1)

Application Number Title Priority Date Filing Date
NO863139A NO168706C (no) 1985-08-06 1986-08-04 Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-heterosyklisk substituerte benzamider.

Country Status (28)

Country Link
US (1) US4772618A (no)
EP (1) EP0213775B1 (no)
JP (1) JPH0662614B2 (no)
KR (1) KR920001763B1 (no)
CN (1) CN1022830C (no)
AR (2) AR243521A1 (no)
AT (1) ATE49206T1 (no)
AU (1) AU596110B2 (no)
CA (1) CA1300154C (no)
DD (1) DD287502A5 (no)
DE (1) DE3667975D1 (no)
DK (1) DK370586A (no)
EG (1) EG18154A (no)
ES (2) ES2000705A6 (no)
FI (1) FI89168C (no)
GB (1) GB8519707D0 (no)
GR (1) GR862060B (no)
HU (1) HU201060B (no)
IE (1) IE58751B1 (no)
IL (1) IL79469A0 (no)
MX (1) MX3375A (no)
MY (1) MY101352A (no)
NO (1) NO168706C (no)
NZ (1) NZ217078A (no)
PH (1) PH25019A (no)
PL (1) PL150228B1 (no)
PT (2) PT83146B (no)
ZA (1) ZA865537B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2640139A1 (fr) * 1988-12-14 1990-06-15 Delagrange Laboratoires Application de benzamides substitues comme gastromoteurs
US5374637A (en) * 1989-03-22 1994-12-20 Janssen Pharmaceutica N.V. N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives
GB9005014D0 (en) * 1990-03-06 1990-05-02 Janssen Pharmaceutica Nv N.(4.piperidinyl)(dihydrobenzofuran or dihydro.2h.benzopyran)carboxamide derivatives
JP2999669B2 (ja) * 1993-08-24 2000-01-17 株式会社三和化学研究所 ベンゾ[b]フランカルボキサミド誘導体、その製法及び用途
JPH0820586A (ja) * 1994-07-05 1996-01-23 Sanwa Kagaku Kenkyusho Co Ltd 1−アザビシクロ[3.3.0]オクタン誘導体、その塩及び製法並びに用途
JPH0873463A (ja) 1994-07-05 1996-03-19 Sanwa Kagaku Kenkyusho Co Ltd ベンゾピランカルボキサミド誘導体、その塩及び製法並びに用途
CN1052228C (zh) * 1996-01-17 2000-05-10 中国科学院大连化学物理研究所 N-甲酰基哌啶及其同系物的制备方法
CN1091104C (zh) * 1998-04-02 2002-09-18 中国科学院大连化学物理研究所 一种n-甲酰基哌啶的制备方法
CN1649766A (zh) 2002-06-11 2005-08-03 安芸电器株式会社 自行车的前照灯以及前照灯电路
PT1704146E (pt) * 2004-01-07 2010-06-30 Aryx Therapeutics Inc Compostos estereoisoméricos e processos para o tratamento de distúrbios gastrointestinais e do sistema nervoso central
GB0525661D0 (en) * 2005-12-16 2006-01-25 Glaxo Group Ltd Novel compounds
EP2619180B1 (en) * 2010-09-01 2014-10-08 Janssen Pharmaceutica, N.V. 5-ht2b receptor antagonists
CN110950843B (zh) * 2019-11-28 2022-12-27 广东东阳光药业有限公司 取代的苯酰胺衍生物及其用途
CN119679732B (zh) * 2024-12-11 2025-10-10 北京阳光诺和药物研究股份有限公司 一种胃肠促动力片剂及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1019781A (no) 1963-03-05
US3342826A (en) 1964-01-13 1967-09-19 Ile De France Heterocyclic aminoalkyl benzamides
GB1507462A (en) * 1974-03-21 1978-04-12 Gallardo Antonio Sa N-heterocyclic substituted benzamides methods for their preparation and compositions containing them
GB1574418A (en) * 1976-11-16 1980-09-03 Anphar Sa Piperidine derivatives
CA1183847A (en) * 1981-10-01 1985-03-12 Georges Van Daele N-(3-hydroxy-4-piperidinyl)benzamide derivatives

Also Published As

Publication number Publication date
JPH0662614B2 (ja) 1994-08-17
CN86105972A (zh) 1987-04-01
GR862060B (en) 1986-12-24
GB8519707D0 (en) 1985-09-11
AU6075886A (en) 1987-02-12
FI89168B (fi) 1993-05-14
EP0213775A1 (en) 1987-03-11
DE3667975D1 (en) 1990-02-08
MX3375A (es) 1993-12-01
AR243521A1 (es) 1993-08-31
CA1300154C (en) 1992-05-05
PT83147A (en) 1986-09-01
NO863139D0 (no) 1986-08-04
HUT44782A (en) 1988-04-28
NO168706B (no) 1991-12-16
KR920001763B1 (ko) 1992-03-02
PL150228B1 (en) 1990-05-31
FI89168C (fi) 1993-08-25
FI863179A7 (fi) 1987-02-07
EP0213775B1 (en) 1990-01-03
AR242793A1 (es) 1993-05-31
MY101352A (en) 1991-09-05
IE58751B1 (en) 1993-11-03
PL260921A1 (en) 1988-01-07
FI863179A0 (fi) 1986-08-04
IE862073L (en) 1987-02-06
PH25019A (en) 1991-01-28
DD287502A5 (de) 1991-02-28
JPS62129279A (ja) 1987-06-11
US4772618A (en) 1988-09-20
ATE49206T1 (de) 1990-01-15
DK370586A (da) 1987-03-27
HU201060B (en) 1990-09-28
AU596110B2 (en) 1990-04-26
ES2000706A6 (es) 1988-03-16
CN1022830C (zh) 1993-11-24
KR870002071A (ko) 1987-03-28
ZA865537B (en) 1987-03-25
PT83146B (pt) 1988-07-29
IL79469A0 (en) 1986-10-31
DK370586D0 (da) 1986-08-04
NZ217078A (en) 1989-01-27
NO168706C (no) 1992-03-25
PT83146A (en) 1986-09-01
PT83147B (pt) 1988-07-29
ES2000705A6 (es) 1988-03-16
EG18154A (en) 1992-11-30

Similar Documents

Publication Publication Date Title
NO860425L (no) Fremgangsmaate ved fremstilling av nye 11-beta-fenylgonaner
NO863574L (no) Fremgangsmaate ved fremstilling av tetrafluorbenzosyre.
NO863139D0 (no) Fremgangsmaate ved fremstilling av nye benzamider.
NO864782D0 (no) Fremgangsmaate ved fremstilling av kinolon-derivater.
NO861474L (no) Fremgangsmaate ved fremstilling av fenetanolaminderivater.
NO860794L (no) Fremgangsmaate ved fremstilling av klordioksyd.
NO862233D0 (no) Fremgangsmaate ved fremstilling av imidazoquinazolinderivater.
NO854577L (no) Fremgangsmaate for fremstilling av nye tienopyridinderivater.
NO863616D0 (no) Fremgangsmaate for fremstilling av n-sulfamyl-3-(2-guanidino-thiazolo-4-yl-methylthio)-propionamid.
NO862270D0 (no) Fremgangsmaate for fremstilling av nye isatinforbindelser.
NO864818D0 (no) Fremgangsmaate for fremstilling av nye terapeutisk virksomme tetrahydroisokinolinderivater.
FI865220A7 (fi) Menetelmä sulfinyyli- ja sulfonyylisubstituoitujen 3-bentsatsepiinien valmistamiseksi.
NO166710C (no) Fremgangsmaate ved fremstilling av uretaner.
NO165538C (no) Fremgangsmaate ved fremstilling av klordioksyd.
NO855353L (no) Fremgangsmaate ved fremstilling av nye allylaminer.
NO862676D0 (no) Analogifremgangsmaate ved fremstilling av terapeutisk virksomme benzamider.
NO860538L (no) Fremgangsmaate ved fremstilling av nye antiallergisk virksomme substanser.
NO863769D0 (no) Fremgangsmaate for fremstilling av 4-hydroksy-2-oksopyrrolin-1-yl-acetamid.
DK63186D0 (da) Fremgangsmaade til fremstilling af trisubstituerede n-phenylurinstofderivater
NO864087L (no) Fremgangsmaate for fremstilling av aroylthiazoloner.
NO863388D0 (no) Fremgangsmaate ved fremstilling av cyclohexanalkansyrer.
IT8620960A0 (it) Procedimento di preparazione di decabromodifeniletere.
NO168245C (no) Analogifremgangsmaate ved fremstilling av nye farmasoeytiskvirksomme sulfamoylbenzoesyrederivater.
NO882172D0 (no) Fremgangsmaate ved fremstilling av nye indansulfonamider.
NO901547D0 (no) Fremgangsmaate ved fremstilling av tetrafluorbenzosyre.